GSA CAPITAL PARTNERS LLP HRTX HERON THERAPEUTICS INC

Ownership history in GSA CAPITAL PARTNERS LLP  ·  20 quarters on record

AI Ownership Summary

GSA CAPITAL PARTNERS LLP reported HERON THERAPEUTICS INC (HRTX) in 20 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 0.11% in 2024 Q2. The latest visible filing shows HRTX at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this HRTX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was GSA CAPITAL PARTNERS LLP's position in HERON THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

HRTX was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.11% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How GSA CAPITAL PARTNERS LLP held HRTX — position size vs. price
% of Fund (quarterly)    HRTX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 105,064 -30,025 -22.2% 0.01% $84 2026-05-08 $1.21
2025 Q4 ADDED 135,089 +34,908 +34.8% 0.02% $176K 2026-02-06 $1.26
2025 Q3 REDUCED 66.3% +4.0% 100,181 -197,140 -66.3% 0.01% $126K 2025-11-07 $1.10
2025 Q2 REDUCED 42.0% -38.6% 297,321 -215,415 -42.0% 0.04% $615K 2025-07-22 $1.90
2024 Q3 ADDED 512,736 +79,680 +18.4% 0.08% $1.0M 2024-11-05 $1.77
2024 Q2 ADDED 433,056 +153,357 +54.8% 0.11% $1.5M 2024-08-15 $1.95
2024 Q1 REDUCED 17.6% +25.3% 279,699 -59,749 -17.6% 0.06% $775K 2024-05-03 $2.61
2023 Q4 ADDED 339,448 +274,920 +426.0% 0.05% $577K 2024-02-16 $2.87
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About GSA CAPITAL PARTNERS LLP and HRTX

These are the practical questions this page is built to answer before you even open the full history table.

How long has GSA CAPITAL PARTNERS LLP reported owning HRTX?

GSA CAPITAL PARTNERS LLP reported HRTX across 8 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported HRTX position in GSA CAPITAL PARTNERS LLP's portfolio?

The largest reported portfolio weight for HRTX was 0.11% in 2024 Q2.

What is the latest reported HRTX position on this page?

The most recent filing on this page is 2026 Q1, when GSA CAPITAL PARTNERS LLP reported 105,064 shares, equal to 0.01% of portfolio, with an estimated market value of $84.

What does the chart on this HRTX ownership page compare?

The chart compares GSA CAPITAL PARTNERS LLP's quarterly HRTX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did GSA CAPITAL PARTNERS LLP time their HRTX position?

Based on 13F filing dates vs. subsequent HRTX price moves, GSA CAPITAL PARTNERS LLP correctly timed 10 out of 19 reported position changes (53%). The annualised alpha on HRTX relative to SPY over the holding period was -58.8%.

← Back to GSA CAPITAL PARTNERS LLP Holdings